HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphangitis carcinomatosis as a potential predictor for a response to gefitinib.

AuthorsT Naito, H Hasegawa, K Asada, T Suda, K Chida
JournalClinical oncology (Royal College of Radiologists (Great Britain)) (Clin Oncol (R Coll Radiol)) Vol. 18 Issue 7 Pg. 573-4 (Sep 2006) ISSN: 0936-6555 [Print] England
PMID16969991 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib
Topics
  • Adenocarcinoma (drug therapy)
  • Antineoplastic Agents (pharmacology)
  • Carcinoma
  • Female
  • Forecasting
  • Gefitinib
  • Humans
  • Lung Neoplasms (drug therapy)
  • Lymphangitis
  • Male
  • Quinazolines (pharmacology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: